Interpace Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	38.73	46.93	40.04	31.84	33.12
Revenue Growth (YoY)	-17.47%	17.21%	25.75%	-3.86%	2.22%
Cost of Revenue	14.6	17	14.98	13.61	14.31
Gross Profit	24.13	29.93	25.06	18.23	18.8
Selling, General & Admin	18.7	21.14	19.6	20.1	19.88
Research & Development	0.64	0.68	0.64	0.7	1.49
Amortization of Goodwill & Intangibles	-	-	0.86	1.27	3.19
Operating Expenses	19.35	21.82	21.09	22.07	24.57
Operating Income	4.78	8.11	3.96	-3.84	-5.76
Interest Expense	-0.17	-0.66	-1.01	-1.01	-1.04
Other Non Operating Income (Expenses)	-0.14	-0.5	-0.67	-1.21	-0.38
EBT Excluding Unusual Items	4.47	6.95	2.29	-6.06	-7.18
Merger & Restructuring Charges	-0.7	-	-	-	-0.9
Other Unusual Items	-	-	-0.01	0.22	0.34
Pretax Income	3.77	6.95	2.28	-5.84	-7.74
Income Tax Expense	-21.21	0	0.02	0.03	-0.71
Earnings From Continuing Operations	24.98	6.95	2.26	-5.87	-7.04
Earnings From Discontinued Operations	-0.41	-0.24	-0.31	-16.09	-7.91
Net Income	24.58	6.7	1.95	-21.96	-14.94
Preferred Dividends & Other Adjustments	-	0.46	-	-	-
Net Income to Common	24.58	6.24	1.95	-21.96	-14.94
Net Income Growth	266.68%	242.99%	-	-	-
Shares Outstanding (Basic)	4	4	4	4	4
Shares Outstanding (Diluted)	28	16	4	4	4
Shares Change (YoY)	76.02%	260.54%	2.97%	2.49%	2.63%
EPS (Basic)	5.55	1.42	0.45	-5.18	-3.61
EPS (Diluted)	0.89	1.39	0.45	-5.18	-3.61
EPS Growth	-36.52%	210.60%	-	-	-
Free Cash Flow	5.48	3.77	3.32	-8.01	-9.07
Free Cash Flow Per Share	0.20	0.24	0.76	-1.89	-2.19
Gross Margin	62.31%	63.77%	62.58%	57.26%	56.78%
Operating Margin	12.35%	17.28%	9.90%	-12.06%	-17.41%
Profit Margin	63.45%	13.29%	4.88%	-68.97%	-45.12%
Free Cash Flow Margin	14.14%	8.03%	8.29%	-25.17%	-27.40%
EBITDA	5.21	8.41	4.99	-1.28	-0.39
EBITDA Margin	13.45%	17.92%	12.46%	-4.02%	-1.18%
D&A For EBITDA	0.43	0.3	1.03	2.56	5.37
EBIT	4.78	8.11	3.96	-3.84	-5.76
EBIT Margin	12.35%	17.28%	9.90%	-12.06%	-17.41%
Effective Tax Rate	-	0.06%	0.74%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.